ArticleBlood advances2023

Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL.

Hui Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.